Dermatology Market Research
Dermatology is the branch of medicine dealing with the skin and its diseases, a unique specialty with both medical and surgical aspects. The dermatology market remains highly competitive. It was observed that the world dermatological market generated total sales revenues of over $18bn in 2007. In future too, this market area is predicted to expand further, increasing its total revenues significantly based on expansion of the market for modern drugs to treat skin disorders in developing countries, most notably China, India and Brazil. As per research, the major dermatological treatments dominating the market under this segment are psoriasis, acne and corticosteroid.
The psoriasis market is forecast to post the most aggressive growth rates over the period to 2011, as Raptiva and Daivobet drive growth over the forecast period. Psoriasis treatments are forecast to expand sales at a CAGR of 12.5%, reaching sales of $1.9bn in 2011. The branded oral acne treatments market is set to decline over the forecast period. Forecast sales of the acne market are estimated at $2.7bn in 2011.
The Dermatology market research report provides insight into the pipeline status of dermatology therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.
The study basically aims at providing a comprehensive overview of the on-goings of the dermatology drug therapy market.